Enzymofit announced that it will receive NIS 1.4 million in equity round of funding on February 22, 2024. The transaction included the participation from new investors EnzymoCore for NIS 1.05 million and hold 75% stake in the company and Feat Fund Investments - Limited Partnership for NIS 350,000 and hold 25% stake in the company.